TeraCyte Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
TeraCyte General Information
Description
Developer of computational models designed to predict cellular responses to various stimuli. The company offers analytical capabilities, facilitating the understanding and forecasting of cell reactions to new drugs or perturbations in the medical field, enabling pharmaceutical researchers and medical professionals to make informed decisions regarding drug development and treatment strategies.
Contact Information
Website
www.teracyte.aiCorporate Office
- Granite Campus
- Ha-Tokhen Street 17, Industrial Park North
- Caesarea
- Israel
Corporate Office
- Granite Campus
- Ha-Tokhen Street 17, Industrial Park North
- Caesarea
- Israel
TeraCyte Timeline
TeraCyte Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 01-Mar-2026 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jun-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 04-Apr-2023 | $1.55M | $1.55M | Completed | Startup |
TeraCyte Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 1 | ||||||||
| Seed 2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
TeraCyte Patents
TeraCyte Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026115390-A1 | System and methods for artificial intelligence inference of cell phenotype using an integrated biosensor | Pending | 26-Nov-2024 | ||
| EP-4623287-A1 | Silicon-on-insulator (soi) carrier chip and methods of manufacture thereof | Pending | 27-Nov-2022 | ||
| US-20250283820-A1 | Silicon-on-insulator (soi) carrier chip and methods of manufacture thereof | Pending | 27-Nov-2022 | ||
| WO-2024110940-A1 | Silicon-on-insulator (soi) carrier chip and methods of manufacture thereof | Inactive | 27-Nov-2022 | ||
| WO-2024110960-A1 | System and methods for temporal image analysis of multi-cell interaction using a carrier chip | Inactive | 23-Nov-2022 | G06T7/0012 |
TeraCyte Signals
TeraCyte Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Stata Capital Partners | Venture Capital | Minority | ||
| MedTech Innovator | Accelerator/Incubator | Minority |
TeraCyte FAQs
-
When was TeraCyte founded?
TeraCyte was founded in 2019.
-
Where is TeraCyte headquartered?
TeraCyte is headquartered in Caesarea, Israel.
-
What is the size of TeraCyte?
TeraCyte has 20 total employees.
-
What industry is TeraCyte in?
TeraCyte’s primary industry is Other Healthcare Technology Systems.
-
Is TeraCyte a private or public company?
TeraCyte is a Private company.
-
What is TeraCyte’s current revenue?
The current revenue for TeraCyte is .
-
How much funding has TeraCyte raised over time?
TeraCyte has raised $1.55M.
-
Who are TeraCyte’s investors?
Stata Capital Partners and MedTech Innovator have invested in TeraCyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process